Search
  1. Home
  2. East Africa
  3. Kenya

Clinton Foundation gives ARVs to 1,000 more kids

    JOHANNESBURG
    Former US President Bill Clinton has launched an initiative to double the number of HIV-positive children receiving anti-AIDS drugs in Kenya. An estimated 100,000 children are living with HIV/AIDS, but only 1,200 have access to antiretroviral (ARV) treatment. Clinton announced that his foundation would provide treatment to about 1,000 more of country's children, the Kaiser Foundation news service reported. The Clinton Foundation programme is to provide paediatric formulations of the life-prolonging medication, bought at a discounted price through a partnership with the India-based generic drug firm, Cipla. A year's supply of ARVs to treat 2,500 HIV-positive children in Rwanda will also be donated by the foundation.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join